Pharmaceutical Technology on MSN

BMS expands DTC offering with Sotyktu addition

Patients will now be able to access BMS' Sotyktu for significantly cheaper than current list prices, alongside BMS and Pfizer ...
The Caledonian-Record

Bristol Myers Squibb Builds on Eliquis® (apixaban) Direct-to-Patient Program, Announces New BMS Patient Connect Platform Offering Sotyktu® (deucravacitinib)

Bristol Myers Squibb (NYSE: BMY) today announced an expansion of its direct-to-patient offerings, providing eligible U.S. patients with steeply discounted prices for Eliquis ® (apixaban) and Sotyktu ® ...
Pharmaceutical Commerce

Bristol Myers Squibb Expands Direct-to-Patient Access With New Sotyktu Program

Through its “BMS Patient Connect” platform, the company is lowering out-of-pocket costs and providing nationwide shipping, ...